【Bora Pharma】February 2026 Revenue: NT$1.326 Billion (YoY -23.2%)
NQ Score
50/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2% decrease year-over-year. As a company specializing in pharmaceutical CDMO within the biotech and healthcare industry, this financial performance reflects the cyclical fluctuations of the sector.
AI analysis data is not yet available.